HD
54
4
TXN
53
3
DG
14
2
GLW
68
4
SLB
56
6
JCI
54
2
VLO
45
3
DUK
62
-2
HON
59
4
NTRS
54
7
WYNN
36
2
URI
63
4
VRSK
38
3
OI
50
7
FITB
60
2
CRM
59
9
AME
59
5
GPC
51
13
NOV
48
3
TEL
66
3
HD
54
4
TXN
53
3
DG
14
2
GLW
68
4
SLB
56
6
JCI
54
2
VLO
45
3
DUK
62
-2
HON
59
4
NTRS
54
7
WYNN
36
2
URI
63
4
VRSK
38
3
OI
50
7
FITB
60
2
CRM
59
9
AME
59
5
GPC
51
13
NOV
48
3
TEL
66
3
Financhill
Back

Regenxbio Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

RGNX
Regenxbio

Last Price:
12.49
Seasonality Move:
5.39%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
127.11
Seasonality Move:
0.19%
Sell
29
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $12.50. The Score for RGNX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $127.10. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $12.50
    The current trend is relatively stagnant and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $127.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.77 Buy
Chaikin Money Flow: -575220 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.58 - 12.56) Buy
Bollinger Bands (100): (11.56 - 14.94) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.72 Sell
Relative Strength Index (14 RSI): 38.7 Sell
Chaikin Money Flow: -11607 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.06 - 139.4) Sell
Bollinger Bands (100): (124.44 - 147.62) Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.53 Sell
20-day SMA: 12.03 Buy
50-day SMA: 12.54 Sell
200-day SMA: 15.68 Sell
8-day EMA: 12.46 Buy
20-day EMA: 12.26 Buy
50-day EMA: 12.51 Sell
200-day EMA: 15 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.94 Buy
20-day SMA: 132.14 Sell
50-day SMA: 138.1 Sell
200-day SMA: 126.4 Buy
8-day EMA: 126.81 Buy
20-day EMA: 130.43 Sell
50-day EMA: 134.6 Sell
200-day EMA: 128.85 Sell

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.42 per share, an increase next quarter of $0.03 per share, an increase this year of $1.03 per share, and an increase next year of $3.83 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):